Comprehensive medication review: development of a collaborative procedure
- 508 Downloads
This commentary describes the development and evidence-base of the Comprehensive Medication Review (CMR) procedure for community and hospital settings in Finland. The development was coordinated by a national steering group. The group collaborated with 26 experienced pharmacists who developed and tested CMR procedures during a 1.5 year accreditation training for CMR. The development consisted of: (1) a literature review and inventory of medication review procedures in different countries; (2) the creation of potential procedures and related documentation; (3) integration of potential procedures into a national standard procedure; and (4) piloting the standard procedure in practice settings. The resulting comprehensive medication review procedure requires access to a patient’s clinical information, an inhome patient interview and a case conference with the collaborating physician. This procedure covers the four main dimensions critical for safe and appropriate geriatric pharmacotherapy: aging and safety; co-morbidities; polypharmacy; and adherence. The CMR measures and documentation build on these dimensions.
KeywordsElderly Finland Medication review Medication safety Pharmacist Pharmacotherapy
The following persons are acknowledged as key members of the steering group responsible for CMR procedure development: Anne Lehtonen, Centre for Pharmacotherapy Development ROHTO; Harri Ovaskainen, The Finnish Pharmacists’ Association; Nina Sevón-Vilkman, Pharmaceutical Learning Centre; Paavo Tanskanen, University of Eastern Finland. The contribution of Dr. Timothy Chen, University of Sydney, Australia is acknowledged to the CMR procedure development.
This study was supported through personal grants (SL) from the Association of Finnish Pharmacies and Pharma Industry Finland Research Foundation.
Conflicts of interest
The authors have no conflicts of interest that are relevant to this manuscript.
- 3.Cipolle R, Strand L, Morley P. Drug therapy problems. In: Pharmaceutical Care Practice. The Clinician’s Guide. 2nd ed. McGraw-Hill: NewYork; 2004. p. 171–200. ISBN: 0-07-136259-2.Google Scholar
- 6.American Pharmacists Association; National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2003;2008(48):341–53.Google Scholar
- 7.The Ministry of Social Affairs and Health, Finland. Safe pharmacotherapy among the aged: obligations for the municipalities (In Finnish). Kuntainfo 6/2007. www.stm.fi/tiedotteet/kuntainfot/kuntainfo/view/1236539. Accessed 2 Sep 2011.
- 9.Hakkarainen K. Models of pharmacists-conducted medication review—An international comparison. Master’s Thesis: University of Helsinki; 2008.Google Scholar
- 11.Leikola S Development and application of a comprehensive medication review procedure to community-dwelling elderly [dissertation]. Helsinki: University of Helsinki; 2012. http://urn.fi/URN:ISBN:978-952-10-7698-5. Accessed 16 May 2012.
- 16.Fimea Database of medication for the elderly. http://www.fimea.fi/medicines/medicines_assesment/database_of_medication. Accessed 20 Sep 2011.
- 17.National Board of Health and Welfare (Socialstyrelsen). Indicators for evaluation of the quality of drug use in the elderly (In Swedish). http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18085/2010-6-29.pdf. Accessed 5 Jun 2011.